Discovery may broaden clinical applications for a class of drugs that show promise for the treatment of familial breast and ovarian cancer.
UAB research team finds protein TLR9 holds key to predicting survival and aggressiveness of triple negative breast cancer.
New director to help establish UAB as the South’s leading center for treating leukemia, lymphoma, multiple myeloma and related diseases.
UAB faculty will give 25 presentations at ASCO scientific meeting; topics also include ovarian and breast cancers and AML, or acute myeloid leukemia.
UAB affiliation provides residents in Okaloosa County and surrounding areas with increased access to advanced cancer care.
Research on how enzymes regulate the progress of a blood cancer wins recognition.
Chow, a pioneer in RNA splicing and in the study of the human papillomavirus, is UAB’s second National Academy member.